India to United States: Torsemide Export Trade Route
India has recorded 284 verified shipments of Torsemide exported to United States, representing a combined trade value of $9.4M USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $33.0K USD. The leading Indian exporter is HETERO LABS LIMITED, which accounts for 44% of total export value with 70 shipments worth $4.1M USD. On the buying side, TO THE ORDER OF is the largest importer in United States with $3.4M USD in purchases. The top 3 suppliers — HETERO LABS LIMITED, HETERO LABS LIMITED, AUROBINDO PHARMA LTD — together control 95% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to United States Torsemide corridor is one of India's established pharmaceutical export routes, with 284 shipments documented worth a combined $9.4M USD. The route is dominated by HETERO LABS LIMITED, which alone accounts for roughly 44% of all export value, reflecting the consolidated nature of India's torsemide manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $33.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with torsemide's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 12.7%, placing it at rank #19 among India's top torsemide export destinations globally.
On the import side, key buyers of Indian torsemide in United States include TO THE ORDER OF, TO THE ORDER OF...., NA and 18 others. TO THE ORDER OF is the single largest importer with 68 shipments valued at $3.4M USD.
Route Characteristics
- Average transit29 days
- Peak seasonQ2
- Primary modeSea freight
- Top portHYDERABAD ICD
Market Position
- Global rank#19
- Annual growth+12.7%
- Demand growth+11.3%
- Regulatory ease75/100
Top 10 Indian Torsemide Exporters to United States
Showing top 10 of 5 Indian suppliers exporting Torsemide to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | HETERO LABS LIMITED Avg $58.9K per shipment | 70 | $4.1M | 44.0% |
| 2 | HETERO LABS LIMITED Avg $26.0K per shipment | 127 | $3.3M | 35.2% |
| 3 | AUROBINDO PHARMA LTD Avg $21.8K per shipment | 67 | $1.5M | 15.6% |
| 4 | AUROBINDO PHARMA LIMITED Avg $24.9K per shipment | 14 | $349.3K | 3.7% |
| 5 | RECIPHARM PHARMASERVICES PRIVATE LIMITED Avg $23.0K per shipment | 6 | $137.8K | 1.5% |
This table shows the top 10 of 5 Indian companies exporting torsemide to United States, ranked by total trade value. The listed exporters are: HETERO LABS LIMITED, HETERO LABS LIMITED, AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, RECIPHARM PHARMASERVICES PRIVATE LIMITED. HETERO LABS LIMITED is the dominant supplier with 70 shipments worth $4.1M USD, giving it a 44% market share. The top 3 suppliers together account for 95% of the total trade value on this route.
Top 10 Torsemide Importers in United States
Showing top 10 of 21 known buyers in United States receiving Torsemide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian torsemide in United States include TO THE ORDER OF, TO THE ORDER OF...., NA, TO THE ORDER, AUROLOGISTICS LLC (AUROBINDO PHARMA, among 21 total buyers. The largest importer is TO THE ORDER OF, accounting for $3.4M USD across 68 shipments — representing 36% of all torsemide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TO THE ORDER OF | 68 | $3.4M | 35.9% |
| 2 | TO THE ORDER OF.... | 72 | $1.8M | 19.2% |
| 3 | NA | 14 | $949.1K | 10.1% |
| 4 | TO THE ORDER | 10 | $533.5K | 5.7% |
| 5 | AUROLOGISTICS LLC (AUROBINDO PHARMA | 22 | $499.0K | 5.3% |
| 6 | CAMBER PHARMACEUTICALS INC | 27 | $423.3K | 4.5% |
| 7 | AUROLOGISTICS LLC AUROBINDO PHARM | 9 | $285.8K | 3.1% |
| 8 | AUROLOGISTICS LLC(AUROBINDO PHARMA | 16 | $279.0K | 3.0% |
| 9 | TO THE ORDER | 4 | $256.7K | 2.7% |
| 10 | AUROLOGISTICS LLC | 10 | $215.5K | 2.3% |
Showing top 10 of 21 Torsemide importers in United States on this route.
Top 10 Torsemide Formulations Imported by United States
Showing top 10 of 83 product formulations shipped on the India to United States Torsemide route, ranked by trade value
United States imports a wide range of torsemide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — TORSEMIDE TABLET — accounts for $2.8M USD across 63 shipments. There are 83 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TORSEMIDE TABLET | 63 | $2.8M | 30.4% |
| 2 | TORSEMIDE 20MG TABLET | 38 | $1.1M | 11.4% |
| 3 | TORSEMIDE TABS | 11 | $743.2K | 7.9% |
| 4 | TORSEMIDE TABS | 11 | $657.6K | 7.0% |
| 5 | TORSEMIDE 20MG TABLETNOS | 30 | $424.0K | 4.5% |
| 6 | TORSEMIDE TABLETNOS | 12 | $220.5K | 2.4% |
| 7 | TORSEMIDE TABLETS 20MG (TORSEMIDE TABLETS USP 20 MG)100'S | 2 | $200.1K | 2.1% |
| 8 | TORSEMIDE TABLETS 20MG (56736X100'S) | 2 | $187.4K | 2.0% |
| 9 | TORSEMIDE 20MG TABS 15888x100 s PACK | 3 | $165.4K | 1.8% |
| 10 | TORSEMIDE 100MG TABS (15720x100's PACK) | 1 | $159.4K | 1.7% |
Showing top 10 of 83 Torsemide formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 73%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD ICD handles the highest volume with 109 shipments. Transit time averages 29 days by sea.
Market Dynamics
India's torsemide exports to United States are driven primarily by a handful of large-scale manufacturers. HETERO LABS LIMITED with 70 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — HETERO LABS LIMITED, HETERO LABS LIMITED, AUROBINDO PHARMA LTD — together account for 95% of total trade value on this route. The average shipment value of $33.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as torsemide 20mg tablet and torsemide tabs, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TO THE ORDER OF is the largest importer with 68 shipments worth $3.4M USD — representing 36% of all torsemide imports from India on this route. A total of 21 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $9.4M
- Avg. Shipment
- $33.0K
- Suppliers
- 5
- Buyers
- 21
- Transit (Sea)
- ~29 days
- Annual Growth
- +12.7%
Reverse Direction
United States → India — Torsemide (Import)Other Torsemide Routes
Unlock the Full India to United States Torsemide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 284 shipments on this route.
Frequently Asked Questions — India to United States Torsemide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Torsemide to United States?
The leading Indian exporters of Torsemide to United States are HETERO LABS LIMITED, HETERO LABS LIMITED, AUROBINDO PHARMA LTD. HETERO LABS LIMITED holds the largest market share at approximately 44% of total trade value on this route.
Q What is the total value of Torsemide exports from India to United States?
India exports Torsemide to United States worth approximately $9.4M USD across 284 recorded shipments. The average value per shipment is $33.0K USD.
Q Which ports does India use to ship Torsemide to United States?
The most active port of origin is HYDERABAD ICD with 109 shipments. Indian exporters primarily use sea freight for this route, with 73% of shipments going by sea and 21% by air.
Q How long does shipping take from India to United States for Torsemide?
The average transit time for Torsemide shipments from India to United States is approximately 29 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Torsemide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 12.7% with demand growth tracking at 11.3%. The route is ranked #19 among India's top Torsemide export destinations globally.
Q How many suppliers are active on the India to United States Torsemide route?
There are currently 5 active Indian suppliers exporting Torsemide to United States. The market is moderately concentrated with HETERO LABS LIMITED accounting for 44% of total shipment value.
Q Who are the main importers of Torsemide from India in United States?
The leading importers of Indian Torsemide in United States include TO THE ORDER OF, TO THE ORDER OF...., NA, TO THE ORDER, AUROLOGISTICS LLC (AUROBINDO PHARMA. TO THE ORDER OF is the largest buyer with 68 shipments worth $3.4M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Torsemide.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 21 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 284 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
284 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists